{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:54:16Z","timestamp":1790873656024,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ghent University Hospital Neuropathology Lab"},{"name":"Ghent University Medicine Faculty"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.cyto.2014.10.012","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T04:13:03Z","timestamp":1417666383000},"page":"81-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Interferons as components of the complex web of reactions sustaining inflammation in idiopathic inflammatory myopathies"],"prefix":"10.1016","volume":"74","author":[{"given":"Boel","family":"De Paepe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2014.10.012_b0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.autrev.2011.05.013","article-title":"Pathogenesis and therapies of immune-mediated myopathies","volume":"11","author":"Dalakas","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cyto.2014.10.012_b0010","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cyto.2014.10.012_b0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.cyto.2014.10.012_b0020","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1212\/WNL.0b013e31821f440a","article-title":"Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies","volume":"76","author":"Cappelletti","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2014.10.012_b0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF02826219","article-title":"Dermatomyositis after interferon alpha treatment","volume":"17","author":"Dietrich","year":"2000","journal-title":"Med Oncol"},{"key":"10.1016\/j.cyto.2014.10.012_b0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2008.12.008","article-title":"Interferon alpha and neuromuscular disorders","volume":"207","author":"Stubgen","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cyto.2014.10.012_b0035","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/archderm.144.10.1341","article-title":"Severe dermatomyositis triggered by interferon beta-1a therapy and associated with enhanced type I interferon signaling","volume":"144","author":"Somani","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cyto.2014.10.012_b0040","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-\u03b1\/\u03b2-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cyto.2014.10.012_b0045","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/art.24555","article-title":"Elevated serum interferon-\u03b1 activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy","volume":"60","author":"Niewold","year":"2009","journal-title":"Arthr Rheum"},{"key":"10.1016\/j.cyto.2014.10.012_b0050","article-title":"Serum interferon-\u03b1 is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis","author":"Horai","year":"2014","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.cyto.2014.10.012_b0055","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/art.22860","article-title":"A possible mechanism for endogenous activation of the type 1 interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/Anti-Ro 60 autoantibodies","volume":"56","author":"Eloranta","year":"2007","journal-title":"Arthr Rheum"},{"key":"10.1016\/j.cyto.2014.10.012_b0060","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/art.38038","article-title":"Interferon-\u03b1 induction and detection of anti-Ro, anti-La, anti-Sm, and anti-RNP autoantibodies by autoantigen microarray analysis in juvenile dermatomyositis","volume":"65","author":"Balboni","year":"2013","journal-title":"Arthr Rheum"},{"key":"10.1016\/j.cyto.2014.10.012_b0065","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/ard.2010.139949","article-title":"Interferon beta is associated with type 1 interferon-inducible gene expression in dermatomyositis","volume":"70","author":"Liao","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2014.10.012_b0070","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/brain\/awn053","article-title":"Interrelation of inflammation and APP in sIBM: IL-1 \u03b2 induces accumulation of \u03b2-amyloid in skeletal muscle","volume":"131","author":"Schmidt","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.cyto.2014.10.012_b0075","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.4049\/jimmunol.168.8.4154","article-title":"Gene expression profiling in DQA1\u22170501+children with untreated dermatomyositis: a novel model of pathogenesis","volume":"168","author":"Tezak","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.10.012_b0080","doi-asserted-by":"crossref","first-page":"e88788","DOI":"10.1371\/journal.pone.0088788","article-title":"Th1 response and systemic Treg deficiency in inclusion body myositis","volume":"9","author":"Allenbach","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2014.10.012_b0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5858\/2008-132-232-MIAOCI","article-title":"Multiplex immunoassay analysis of cytokines in idiopathic inflammatory myopathy","volume":"132","author":"Baird","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cyto.2014.10.012_b0090","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/ard.2007.077974","article-title":"A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies","volume":"67","author":"Dastmalchi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2014.10.012_b0095","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.ajpath.2012.08.033","article-title":"Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile","volume":"181","author":"Preuse","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2014.10.012_b0100","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/art.1780400514","article-title":"Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies","volume":"40","author":"Lundberg","year":"1997","journal-title":"Arthr Rheum"},{"key":"10.1016\/j.cyto.2014.10.012_b0105","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.ajpath.2011.05.055","article-title":"Laser microdissection reveals differential up-regulation of IFN-\u03b3 signaling cascade in attacked versus nonattacked myofibers","volume":"179","author":"Ivanidze","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2014.10.012_b0110","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/ard.2006.068858","article-title":"Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2014.10.012_b0115","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/nar\/gkn732","article-title":"INTERFEROME: the database of interferon regulated genes","volume":"37","author":"Samarajiwa","year":"2008","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.cyto.2014.10.012_b0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/gene.2011.61","article-title":"Relationship between disease activity and type 1 interferon-and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis","volume":"13","author":"Greenberg","year":"2012","journal-title":"Genes Immun"},{"key":"10.1016\/j.cyto.2014.10.012_b0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.21805","article-title":"Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy","volume":"67","author":"Salajegheh","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cyto.2014.10.012_b0130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/path.4346","article-title":"Altered RIG-I\/DDX58-mediated innate immunity in dermatomyositis","volume":"5","author":"Suarez-Calvet","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.cyto.2014.10.012_b0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0022-510X(89)90023-3","article-title":"Expression of class I and class II MHC antigens in neuromuscular diseases","volume":"89","author":"McDouall","year":"1989","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.cyto.2014.10.012_b0140","first-page":"450","article-title":"Localization of IFN and interleukin 2 in polymyositis and muscular dystrophy","volume":"63","author":"Isenberg","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2014.10.012_b0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/PAI.0b013e31827d7f16","article-title":"Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy","volume":"21","author":"Das","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.cyto.2014.10.012_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2014.06.436","article-title":"An analysis of the sensitivity and specificity of MHC-I and MHC-II immunohistochemical staining in muscle biopsies for the diagnosis of inflammatory myopathies","author":"Rodriguez Cruz","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.cyto.2014.10.012_b0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1440-1789.1994.tb00232.x","article-title":"Sarcolemmal coexpression of intercellular adhesion molecule-1 (ICAM-1) and HLA-DR in inflammatory myopathy","volume":"14","author":"Shimizu","year":"2007","journal-title":"Neuropathol"},{"key":"10.1016\/j.cyto.2014.10.012_b0160","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9440(10)62513-8","article-title":"Skeletal muscle fibres express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies","volume":"159","author":"Englund","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2014.10.012_b0165","first-page":"1142","article-title":"Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes","volume":"143","author":"Michaelis","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2014.10.012_b0170","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<385::AID-MUS10>3.0.CO;2-T","article-title":"Expression of HLA-DR and its enhancing molecules in muscle fibres in polymyositis","volume":"23","author":"Inukai","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cyto.2014.10.012_b0175","first-page":"1142","article-title":"Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes","volume":"143","author":"Michaelis","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2014.10.012_b0180","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.3899\/jrheum.080418","article-title":"Upregulation of myxovirus-resistance protein A: a possible marker of type I interferon induction in systemic sclerosis","volume":"35","author":"Airo","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2014.10.012_b0185","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthr Rheum"},{"key":"10.1016\/j.cyto.2014.10.012_b0190","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clim.2006.05.011","article-title":"MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement","volume":"120","author":"O\u2019Connor","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cyto.2014.10.012_b0195","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend of foe?","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.10.012_b0200","first-page":"375","article-title":"Mechanisms of type-I-and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev"},{"key":"10.1016\/j.cyto.2014.10.012_b0205","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","article-title":"IRF family of transcription factors as regulators of host defense","volume":"19","author":"Taniguchi","year":"2001","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.cyto.2014.10.012_b0210","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.3389\/fimmu.2013.00281","article-title":"Aberrant type I interferon regulation in autoimmunity: opposite directions in MS and SLE, shaped by evolution and body ecology","volume":"4","author":"Reder","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.cyto.2014.10.012_b0215","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-2133.2012.11145.x","article-title":"Dysregulation of the type 1 interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease","volume":"167","author":"Sun","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cyto.2014.10.012_b0220","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1038\/emm.2013.36","article-title":"ISG15: leading a double life as a secreted molecule","volume":"45","author":"Bogunovic","year":"2013","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.cyto.2014.10.012_b0225","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/ar2885","article-title":"Type 1 interferons and myositis","volume":"12","author":"Greenberg","year":"2010","journal-title":"Arthr Res Ther"},{"issue":"1","key":"10.1016\/j.cyto.2014.10.012_b0230","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri3344","article-title":"The broad-spectrum antiviral functions of IFIT and IFITM proteins","volume":"13","author":"Diamond","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2014.10.012_b0235","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","article-title":"RNA helicase encoded by melanoma differentiation-associated gene 5 is a major auto antigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease","volume":"60","author":"Sato","year":"2009","journal-title":"Arthr Rheum"},{"key":"10.1016\/j.cyto.2014.10.012_b0240","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/08916934.2013.796937","article-title":"Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: a meta-analysis","volume":"46","author":"Cen","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cyto.2014.10.012_b0245","first-page":"S256","article-title":"MDA-5 associated myositis: towards a molecular and morphological definition of a distinct entity","volume":"1","author":"Allenbach","year":"2014","journal-title":"J Neuromusc Dis"},{"key":"10.1016\/j.cyto.2014.10.012_b0250","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1172\/JCI17129","article-title":"Interplay between IFN-\u03b3 and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation","volume":"112","author":"McLoughlin","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2014.10.012_b0255","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.24936","article-title":"Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis","volume":"60","author":"Bilgic","year":"2009","journal-title":"Arthr Rheum"},{"key":"10.1016\/j.cyto.2014.10.012_b0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/jir.2007.0062","article-title":"Benveniste EN (2008) IFN-\u03b2 -mediated inhibition of IL-8 expression requires the ISGF3 components Stat1, Stat2, and IRF-9","volume":"28","author":"Laver","year":"2008","journal-title":"J Interferon Cytok Res"},{"key":"10.1016\/j.cyto.2014.10.012_b0265","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/intimm\/12.2.151","article-title":"IL-12 synergizes with IL-18 or IL-1 \u03b2 for IFN-\u03b3 production from human T cells","volume":"12","author":"Tominaga","year":"2000","journal-title":"Int Immunol"},{"key":"10.1016\/j.cyto.2014.10.012_b0270","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.2006.03180.x","article-title":"Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies","volume":"146","author":"Tucci","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2014.10.012_b0275","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1084\/jem.20031942","article-title":"Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes","volume":"199","author":"Boule","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.10.012_b0280","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1189\/jlb.0412210","article-title":"Induction of BAFF expression by IFN-\u03b3 via JAK\/STAT signaling pathways in human intestinal epithelial cells","volume":"93","author":"Woo","year":"2013","journal-title":"J Leukocyte Biol"},{"key":"10.1016\/j.cyto.2014.10.012_b0285","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneuroim.2012.04.006","article-title":"The expression of BAFF in the muscles of patients with dermatomyositis","volume":"249","author":"Baek","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cyto.2014.10.012_b0290","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1189\/jlb.0507273","article-title":"Novel interferon-\u03b2 -induced gene expression in peripheral blood cells","volume":"82","author":"Rani","year":"2007","journal-title":"J Leukocyte Biol"},{"key":"10.1016\/j.cyto.2014.10.012_b0295","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/intimm\/12.9.1329","article-title":"Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation","volume":"12","author":"De Rossi","year":"2000","journal-title":"Int Immunol"},{"key":"10.1016\/j.cyto.2014.10.012_b0300","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cyto.2010.01.009","article-title":"Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"50","author":"Antonelli","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2014.10.012_b0305","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00401-005-0989-5","article-title":"Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies","volume":"109","author":"De Paepe","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.cyto.2014.10.012_b0310","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1002\/art.21303","article-title":"Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy","volume":"52","author":"Fall","year":"2005","journal-title":"Arthr Rheum"},{"key":"10.1016\/j.cyto.2014.10.012_b0315","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/mi.2012.46","article-title":"IFN-\u03b1 -driven CCL2 production recruits inflammatory monocytes to infection site in mice","volume":"6","author":"Conrady","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.cyto.2014.10.012_b0320","first-page":"117","article-title":"Induction of macrophage-inflammatory protein 1 alpha (MIP-1alpha) by interferon-alpha","volume":"26","author":"Bug","year":"1998","journal-title":"Exp Hematol"},{"key":"10.1016\/j.cyto.2014.10.012_b0325","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1212\/WNL.58.12.1779","article-title":"Differential expression of chemokines in inflammatory myopathies","volume":"58","author":"De Bleecker","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2014.10.012_b0330","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/BOR.0b013e3283317b31","article-title":"Role of cytokines and chemokines in idiopathic inflammatory myopathies","volume":"21","author":"De Paepe","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.cyto.2014.10.012_b0335","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/rheumatology\/ket413","article-title":"Suppression of soluble T cell-associated proteins by an anti-interferon-\u03b1 monoclonal antibody in adult patients with dermatomyositis or polymyositis","volume":"53","author":"Guo","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.cyto.2014.10.012_b0340","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.7510419","article-title":"Requirement for transcription factor IRF-1 in NO synthase induction in macrophages","volume":"18","author":"Kamijo","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cyto.2014.10.012_b0345","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-004-0859-6","article-title":"Expression and distribution of the nitric oxide synthases in idiopathic inflammatory myopathies","volume":"108","author":"De Paepe","year":"2004","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.cyto.2014.10.012_b0350","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2990.2012.01302.x","article-title":"Immune-mediated necrotizing myopathies \u2013 a heterogeneous group of diseases with specific myopathological features","volume":"38","author":"Stenzel","year":"2012","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.cyto.2014.10.012_b0355","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/brain\/aws046","article-title":"Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase presents interleukin-1 \u03b2-induced accumulation of \u03b2-amyloid and cell death","volume":"135","author":"Schmidt","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.cyto.2014.10.012_b0360","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/mus.23465","article-title":"Nitric oxide prevents atorvastatin-induced skeletal muscle dysfunction and alterations in mice","volume":"47","author":"D\u2019Antona","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cyto.2014.10.012_b0365","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood.V84.12.4008.bloodjournal84124008","article-title":"IL-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes","volume":"84","author":"Trichieri","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2014.10.012_b0370","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.177.3.1416","article-title":"Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection","volume":"177","author":"Cruz","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.10.012_b0375","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009742.2010.517215","article-title":"Interleukin-17 and interleukin-23 in patients with polymyositis and dermatomyositis","volume":"40","author":"Shen","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.cyto.2014.10.012_b0380","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/annrheumdis-2012-202794","article-title":"A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-\u03b1 monoclonal antibody, shows target neutralization of a type 1 IFN signature in blood of dermatomyositis and polymyositis patients","volume":"73","author":"Higgs","year":"2014","journal-title":"Ann Rheum Dis"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614005560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614005560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T21:14:59Z","timestamp":1650748499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466614005560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1043466614005560"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2014.10.012","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferons as components of the complex web of reactions sustaining inflammation in idiopathic inflammatory myopathies","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2014.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}